J
Junko Terada-Hirashima
Publications - 15
Citations - 260
Junko Terada-Hirashima is an academic researcher. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 3, co-authored 4 publications receiving 56 citations.
Papers
More filters
Journal ArticleDOI
Clinical epidemiology of hospitalized patients with COVID-19 in Japan: Report of the COVID-19 REGISTRY JAPAN.
Nobuaki Matsunaga,Kayoko Hayakawa,Mari Terada,Hiroshi Ohtsu,Yusuke Asai,Shinya Tsuzuki,Setsuko Suzuki,Ako Toyoda,Kumiko Suzuki,Mio Endo,Naoki Fujii,Michiyo Suzuki,Sho Saito,Yukari Uemura,Taro Shibata,Masashi Kondo,Kazuo Izumi,Junko Terada-Hirashima,Ayako Mikami,Wataru Sugiura,Norio Ohmagari +20 more
TL;DR: The clinical epidemiological features of COVID-19 in hospitalized patients in Japan demonstrated fewer comorbidities and a trend towards lower mortality when compared with existing inpatient studies in other countries.
Journal ArticleDOI
A novel highly quantitative and reproducible assay for the detection of anti-SARS-CoV-2 IgG and IgM antibodies.
Kenta Noda,Kouki Matsuda,Shigehiro Yagishita,Kenji Maeda,Yutaro Akiyama,Junko Terada-Hirashima,Hiromichi Matsushita,Satoshi Iwata,Kazuto Yamashita,Yusuke Atarashi,Shunsuke Watanabe,Nobuyuki Ide,Tomokazu Yoshida,Norio Ohmagari,Hiroaki Mitsuya,Hiroaki Mitsuya,Akinobu Hamada +16 more
TL;DR: In this article, the authors developed a diagnostic test that detects SARS-CoV-2 IgG and IgM with high quantitativeness and reproducibility and low interference.
Journal ArticleDOI
Human Gut Microbiota and Its Metabolites Impact Immune Responses in COVID-19 and Its Complications
Naoyoshi Nagata,Tadashi Takeuchi,Hiroaki Masuoka,Ryo Aoki,Masahiro Ishikane,Noriko Iwamoto,Masaya Sugiyama,Wataru Suda,Yumiko Nakanishi,Junko Terada-Hirashima,Moto Kimura,Tomohiko Nishijima,Hiroshi Inooka,Tohru Miyoshi-Akiyama,Yasushi Kojima,Chikako Shimokawa,Hajime Hisaeda,Fen Zhang,Yun Kit Yeoh,Siew C. Ng,Naomi Uemura,Takao Itoi,Masashi Mizokami,Takashi Kawai,Haruhito Sugiyama,Norio Ohmagari,Hiroshi Ohno +26 more
TL;DR: Multi-omics analysis revealed multiple gut microbe-metabolite-cytokine interrelationships in CO VID-19 and COVID-19-related complications, but few in GI complications, suggesting microbiota-mediated immune responses distinct between the organ sites.
Journal ArticleDOI
Efficacy and Safety of Inhaled Ciclesonide in Treating Patients With Asymptomatic or Mild COVID-19 in the RACCO Trial: Protocol for a Multicenter, Open-label, Randomized Controlled Trial
Junko Terada-Hirashima,Manabu Suzuki,Yukari Uemura,Masayuki Hojo,Ayako Mikami,Wataru Sugiura,Norio Ohmagari,Haruhito Sugiyama +7 more
TL;DR: If the hypotheses that pneumonia exacerbation rate reduction is more significant in the cicleonide treatment group than in the symptomatic treatment group and that ciclesonide is safe for use are valid, cicles onide (Alvesco R) will serve as an important therapeutic option for COVID-19 patients.
Journal ArticleDOI
COVID-19 and bronchial asthma: current perspectives
TL;DR: Analysis of the expression of ACE2 and TMPRSS2 in asthma patients is identical (or less common) to that of healthy participants, and it could be speculated that asthma patients are not susceptible to COVID-19.